Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myostatin
, a member of TGF-beta superfamily of growth factors, acts as a negative regulator of skeletal muscle mass. The mechanism whereby
myostatin
controls the proliferation and differentiation of myogenic cells is mostly clarified. However, the regulation of
myostatin
activity to myogenic cells after its secretion in the extracellular matrix (ECM) is still unknown. Decorin, a small leucine-rich proteoglycan, binds TGF-beta and regulates its activity in the ECM. Thus, we hypothesized that decorin could also bind to
myostatin
and participate in modulation of its activity to myogenic cells. In order to test the hypothesis, we investigated the interaction between
myostatin
and decorin by surface plasmon assay. Decorin interacted with mature
myostatin
in the presence of concentrations of Zn(2+) greater than 10microM, but not in the absence of Zn(2+). Kinetic analysis with a 1:1 binding model resulted in dissociation constants (K(D)) of 2.02x10(-8)M and 9.36x10(-9)M for decorin and the core protein of decorin, respectively. Removal of the glycosaminoglycan chain by
chondroitinase
ABC digestion did not affect binding, suggesting that decorin could bind to
myostatin
with its core protein. Furthermore, we demonstrated that immobilized decorin could rescue the inhibitory effect of
myostatin
on myoblast proliferation in vitro. These results suggest that decorin could trap
myostatin
and modulate its activity to myogenic cells in the ECM.
...
PMID:Decorin binds myostatin and modulates its activity to muscle cells. 1638 93